▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Todd Campbell

tmfebcapital

@ebcapital

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Recent Articles by Todd Campbell

GettyImages-1027702396

Sep 16, 2021 by Todd Campbell

Why Your Social Security Income Could Increase 5% (or More) in 2022

Inflation could mean retirees will pocket the biggest Social Security cost-of-living (COLA) adjustment in decades.

GettyImages-1257831289

Sep 8, 2021 by Todd Campbell

Retiring at 70? Here's the Maximum You Can Collect in Social Security Income

If you're planning to collect Social Security at age 70 this year, then this is the most you can collect in monthly benefits.

warren-buffett-buys-apple-stock_large_large

Aug 21, 2021 by Todd Campbell

Here Are Warren Buffett's Biggest Stock Picks

Berkshire Hathaway's top holdings include a technology stock, two financial giants, and two of the best known consumer brands companies in the world.

GettyImages-987809042

Aug 20, 2021 by Todd Campbell

Could Social Security Recipients Get a Big Raise Next Year?

Social Security payments could be heading higher because of inflation.

Aug 17, 2021 by Todd Campbell

Top Stocks Warren Buffett Just Bought

These were Berkshire Hathaway's biggest buys during Q2, 2021.

GettyImages-116377246

Jul 15, 2021 by Todd Campbell

Social Security Benefits Could Skyrocket Next Year

Social Security payments could increase by the largest amount in nearly 40 years in 2022.

GettyImages-1142670707

Jul 10, 2021 by Todd Campbell

Retiring Early? Here's The Top Social Security Income at Age 62

If you're planning to begin receiving Social Security at age 62 this year, then this is the maximum you can collect in benefits.

GettyImages-1022809050

Jul 1, 2021 by Todd Campbell

Here's the Maximum Social Security Benefit in 2021

Social Security's maximum payment may surprise you.

GettyImages-922562358

Jun 24, 2021 by Todd Campbell

Here's How Much the Average Person Collects in Social Security Benefits

The average amount Social Security recipients receive monthly may surprise you.

GettyImages-143070893

Jun 17, 2021 by Todd Campbell

Social Security Recipients Could Get a Big Raise Next Year

Social Security payments could climb significantly this year because of inflation.

GettyImages-1311564458

Jun 10, 2021 by Todd Campbell

Moderna Files For FDA Approval of Its COVID Vaccine In Teens

The company hopes to secure emergency use authorization from regulators for the use of its COVID vaccine in children aged 12 to 18.

GettyImages-1160800655

Jun 9, 2021 by Todd Campbell

Merck Cuts a Billion-Dollar COVID Deal

The U.S. government will pay $1.2 billion for 1.7 billion doses of Merck's experimental oral COVID-19 drug.

GettyImages-1302453847

Jun 9, 2021 by Todd Campbell

Vertex Pharmaceuticals Nabs Key FDA Approval In Cystic Fibrosis

The Food and Drug Administration has expanded eligibility for Trikafta to include amenable cystic fibrosis patients aged 6 through eleven.

GettyImages-949110884

Jun 8, 2021 by Todd Campbell

Senator Takes Aim at Biogen's New Alzheimer's Drug

Sen. Ron Wyden calls Aduhelm's $56,000 price tag "unconscionable."

GettyImages-1214079126

Jun 7, 2021 by Todd Campbell

Biogen's New Alzheimer's Drug Will Cost $56,000 Per Year

Biogen set the list price for Aduhelm, its newly approved treatment; and is collaborating with CVS to improve screening for the disease.

GettyImages-1175270464

Jun 7, 2021 by Todd Campbell

Bluebird bio Can Restart Halted Clinical Trials

The FDA has lifted the hold on bluebird bio's gene-therapy studies in sickle cell disease and transfusion-dependent β-thalassemia.

GettyImages-637107694

Apr 13, 2021 by Todd Campbell

Independent Monitors Suggest Shorter Timeline for Novocure's Lung Cancer Treatment

A trial examining the use of Novocure's tumor-treating field technology in non-small cell lung cancer patients could enroll fewer patients over a shorter period, based on recommendations by an independent committee.

GettyImages-1012405368

Mar 10, 2021 by Todd Campbell

bluebird bio Says Its Drug "Unlikely" to Have Caused Blood Cancer

A clinical hold on the biotech company could be lifted following Bluebird's results.

warren-buffett-buys-apple-stock_large_large

Nov 19, 2020 by Todd Campbell

Warren Buffett Just Bought These Stocks

Berkshire Hathaway's 13-F filing shows the Oracle of Omaha's bullish on healthcare.

GettyImages-1132186568

Nov 17, 2020 by Todd Campbell

Amazon Opens an Online Pharmacy

The e-commerce giant's new pharmacy will deliver prescription drugs throughout most of the U.S.

HOW THE MOTLEY FOOL CAN HELP YOU

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services